Search Results - "Anne Marie Lane"

Refine Results
  1. 1

    CFH and ARMS2 Genetic Polymorphisms Predict Response to Antioxidants and Zinc in Patients with Age-related Macular Degeneration by Awh, Carl C., MD, Lane, Anne-Marie, MPH, Hawken, Steven, MSc, Zanke, Brent, MD, PhD, Kim, Ivana K., MD

    Published in Ophthalmology (Rochester, Minn.) (01-11-2013)
    “…Objective The Age-Related Eye Disease Study (AREDS) demonstrated that antioxidant and zinc supplementation decreases progression to advanced age-related…”
    Get full text
    Journal Article
  2. 2

    A Broadly Applicable Surgical Teaching Method: Evaluation of a Stepwise Introduction to Cataract Surgery by Kloek, Carolyn E., MD, Borboli-Gerogiannis, Sheila, MD, Chang, Kenneth, MD, Kuperwaser, Mark, MD, Newman, Lori R., MEd, Marie Lane, Anne, MPH, Loewenstein, John I., MD

    Published in Journal of surgical education (01-03-2014)
    “…Objective Although cataract surgery is one of the most commonly performed surgeries in the country, it is a microsurgical procedure that is difficult to learn…”
    Get full text
    Journal Article
  3. 3

    Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families by Njauw, Ching-Ni Jenny, Kim, Ivana, Piris, Adriano, Gabree, Michele, Taylor, Michael, Lane, Anne Marie, DeAngelis, Margaret M, Gragoudas, Evangelos, Duncan, Lyn M, Tsao, Hensin

    Published in PloS one (24-04-2012)
    “…BAP1 has been shown to be a target of both somatic alteration in high-risk ocular melanomas (OM) and germline inactivation in a few individuals from…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea by Patel, Avni V., MD, MBA, Lane, Anne Marie, MPH, Morrison, Margaux A., MPH, Trofimov, Alexei V., PhD, Shih, Helen A., MD, Gragoudas, Evangelos S., MD, Kim, Ivana K., MD

    Published in Ophthalmology (Rochester, Minn.) (01-02-2016)
    “…Purpose To report visual outcomes in patients undergoing proton beam irradiation of tumors located within 1 disc diameter of the fovea. Design Retrospective…”
    Get full text
    Journal Article
  7. 7

    Adjuvant Interferon Therapy for Patients with Uveal Melanoma at High Risk of Metastasis by Lane, Anne Marie, MPH, Egan, Kathleen M., ScD, Harmon, David, MD, Holbrook, Amy, MS, Munzenrider, John E., MD, Gragoudas, Evangelos S., MD

    Published in Ophthalmology (Rochester, Minn.) (01-11-2009)
    “…Purpose To examine whether interferon (IFN)-alfa-2a treatment after radiation or enucleation reduces death rates in patients with uveal melanoma. Design…”
    Get full text
    Journal Article
  8. 8

    Natural History of Radiation Papillopathy after Proton Beam Irradiation of Parapapillary Melanoma by Kim, Ivana K., MD, Lane, Anne Marie, MPH, Egan, Kathleen M., ScD, Munzenrider, John, MD, Gragoudas, Evangelos S., MD

    Published in Ophthalmology (Rochester, Minn.) (01-08-2010)
    “…Purpose To evaluate the natural history of radiation papillopathy after proton beam irradiation of parapapillary choroidal melanoma. Design Noncomparative case…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Risk factors for radiation maculopathy and papillopathy after intraocular irradiation by Gragoudas, E S, Li, W, Lane, A M, Munzenrider, J, Egan, K M

    Published in Ophthalmology (Rochester, Minn.) (01-08-1999)
    “…To evaluate rates of occurrence and risk factors for radiation maculopathy and radiation papillopathy in patients with choroidal melanoma at high risk for…”
    Get more information
    Journal Article
  13. 13

    Uveal melanoma: proton beam irradiation by Gragoudas, Evangelos S, Marie Lane, Anne

    Published in Ophthalmology clinics of North America (01-03-2005)
    “…Over the past two decades, radiotherapy has replaced enucleation as the standard treatment for uveal melanoma. Although this method does not alter survival,…”
    Get more information
    Journal Article
  14. 14

    Ocular blood flow velocity in age-related macular degeneration by Friedman, E, Krupsky, S, Lane, A M, Oak, S S, Friedman, E S, Egan, K, Gragoudas, E S

    Published in Ophthalmology (Rochester, Minn.) (01-04-1995)
    “…Changes in the structure of the ocular blood vessels associated with age-related macular degeneration (AMD) have been described in some detail, but…”
    Get more information
    Journal Article
  15. 15
  16. 16

    Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy by Lane, Anne Marie, Kim, Ivana K, Gragoudas, Evangelos S

    Published in JAMA ophthalmology (01-07-2015)
    “…Little is known about the long-term risk of dying of uveal melanoma after treatment with radiotherapy. To determine the long-term risk of dying of this…”
    Get more information
    Journal Article
  17. 17

    Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas by Papakostas, Thanos D, Lane, Anne Marie, Morrison, Margaux, Gragoudas, Evangelos S, Kim, Ivana K

    Published in JAMA ophthalmology (01-11-2017)
    “…Although radiotherapy has been used more frequently in past decades for the management of large melanomas, long-term efficacy of proton beam irradiation (PBI)…”
    Get more information
    Journal Article
  18. 18

    Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations by Gupta, Mrinali P, Lane, Anne Marie, DeAngelis, Margaret M, Mayne, Katie, Crabtree, Margaux, Gragoudas, Evangelos S, Kim, Ivana K

    Published in JAMA ophthalmology (01-08-2015)
    “…Somatic mutations in BAP1 (BRCA1-associated protein 1 gene) are frequently identified in uveal melanoma. To date, the role of germline BAP1 mutations in uveal…”
    Get more information
    Journal Article
  19. 19

    Growth rate of indeterminate choroidal lesions prior to melanoma diagnosis by Wu, Frances, Lane, Anne Marie, Oxenreiter, Monica M., Gragoudas, Evangelos S., Kim, Ivana K.

    “…Purpose Small choroidal melanocytic lesions have a low rate of metastasis and can be reasonably managed with surveillance until they demonstrate evidence of…”
    Get full text
    Journal Article
  20. 20